Compare Davita Inc (DVA) vs Gitlab Inc (GTLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Gitlab Inc — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while Gitlab Inc trades at $53.9 (market cap $8.92B). The key difference: Davita Inc is the larger of the two by market cap, and Gitlab Inc is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Gitlab Inc for 62 Days on average.
| DVA | GTLB | |
|---|---|---|
Market Cap | $11.29B | $8.92B |
Volume | 582,204 | 4,716,893 |
Sector | Health | Technology |
52-Week High | $240.96 | $53.56 |
52-Week Low | $103.87 | $19.42 |
Typical Hold Time | 113 Days | 62 Days |
Enterprise Value | $24.01B | $7.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
GitLab (GTLB) trades at $51.99, up 0.7% with strong bullish technical momentum. The stock shows impressive revenue growth from $759M in 2025 to projected $1.1B in 2026, though profitability remains challenged with a -4.99% net margin. Recent Q2 2026 earnings beat expectations with $0.24 EPS versus $0.18 expected, driving positive sentiment. The company's AI-driven DevSecOps platform is gaining traction, with agentic automation features and Flex bookings showing strong momentum according to recent earnings calls.
Outlook remains cautiously optimistic with 36.7% analyst buy ratings but elevated valuation metrics (P/E 521, P/S 8.3) present risk. Key opportunities include AI product adoption and enterprise expansion, while risks center on profitability timeline and competitive pressures. The consensus price target of $49.71 suggests limited upside from current levels despite recent operational improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Gitlab Inc
GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →
